Post by
Turtle4 on Jun 28, 2024 12:06pm
New all time low at 0.04 cad?
Congratulation. What a transformational year!
Comment by
Pareto8020 on Jun 28, 2024 1:39pm
It takes a special kind of stupid to sign a contract with a major pharma and then run your stock price into the ground. Congrat's Howie - you show them how its done!
Comment by
bealert on Jun 28, 2024 2:02pm
Happy to report that the all time low was about 12 years ago @ 3 cents. So 4 cents is 33.333333% better than 3 cents. WOW. Last trade was at 5 cents so that's an incredible increase from 3 cents! Good luck to all as we march to the drug store for more ulcer medication, thanks to honest howey, and all of those who helped him sucker us. BeAlert
Comment by
Turtle4 on Jun 28, 2024 5:29pm
In fact, I only checked the 10-year chart.... But you can see from the chart: History repeats itself. So let's wait for the next spike and this time really sell before everything collapses again.
Comment by
MirrorWorldMan on Jun 29, 2024 12:02pm
We are at a worthless penny stock at this point. Only a buyout or tangible expectation of revenue will help. Howie needs to stop with this, "we are pleased to report..." alpo and present NR about the AbbVie deal.
Comment by
Turtle4 on Jul 01, 2024 3:29pm
Insiders often buy when the share price has fallen so sharply. On the one hand to exude confidence, or simply to make good money if they are convinced that things will go up again. Unfortunately, neither is the case here... And I don't believe that insider information prohibits them from trading. Abbvie will probably only let you know after the official release.
Comment by
Pandora on Jul 01, 2024 11:01pm
I don't remember seeing a clause that said it would be a minimum of 2 years or longer before a product launch would happen or that all interval payments would not start until the "Launch" happened.
Comment by
Turtle4 on Jul 03, 2024 2:27am
Linda did a great job. She has negotiated such high royalties that it is no longer worthwhile for Allergan and they are focusing on their own products instead. After all, tfc1067 is off the market. Allergan is paying the small contractual penalty out of its petty cash.
Comment by
lscfa on Jul 03, 2024 8:31pm
I don't know what PRC got for that pump but they should have got life.
Comment by
Turtle4 on Jul 04, 2024 3:47am
I think the PRC figures would be quite realistic if the license went to a global cosmetics company. Skinmedica is only really represented in North America. The large skin lightening market will probably not be penetrated but only the high-priced dark spot market (ethical requirements...) and that is only a small fraction of the market.